HPV Immunization Status
Conditions
Keywords
MCV4: Meningococcal Conjugate Vaccine, HPV: Human Papillomavirus
Brief summary
The purpose of this study is to determine if a multimodal Human Papillomavirus (HPV) immunization program carried out in pediatric and family medicine practices would be more effective in improving adolescent patients' HPV immunization rates than the usual care provided to adolescents in pediatric and family medicine practices.
Interventions
BEHAVIORALMultimodal Vaccine Program
Efforts will be made to collaborate with pediatric and family medicine offices to utilize a multimodal intervention to improve adolescents' HPV immunization rates. As part of the overall intervention, four intervention strategies will be used: 1) a tailored website, iVac -HPV , 2) Motivational Interview Training for providers, 3) HPV Fact Sheets and 4) The Decision Aid for HPV Vaccines
Sponsors
Centers for Disease Control and Prevention
University of Colorado, Denver
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Subject)
Eligibility
Sex/Gender
ALL
Age
9 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
for immunization rate assessment: 1. 9 years of age or older when presenting for care 2. Patients who present for care one year prior to the start of the intervention and up to two years after the start of the intervention
Exclusion criteria
1. Less than 9 years of age when presenting for care 2. Patient is not eligible for HPV immunization Provider survey: Providers who are working at participating practices during the two times a cross-sectional survey is administered. Parent survey: Parents of adolescents who presented for care within one 1 year prior to the two times a cross-sectional survey is administration.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| The percentage of adolescents who initiate the HPV vaccine series | 1 year | The percent of eligible patients presenting for care at intervention offices who receive one or more HPV vaccines (using administrative, Electronic Medical Records (EMR), and Colorado Immunization Information System (CIIS) immunization data), during the intervention year, compared to the percent in control offices. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| The percentage of adolescents who receive MCV4 vaccine | 1 year | The percent of eligible patients presenting for care at intervention offices who receive MCV4 vaccine (using administrative, EMR and CIIS immunization data) compared to the percent in control offices. |
| The percentage of adolescents who receive Tdap vaccine | 1 year | The percentage of eligible patients presenting for care at intervention offices who receive Tetanus, Diphtheria, Pertussis (Tdap) vaccine (using administrative, EMR and CIIS immunization data) during the intervention year compared to the percent in control offices. |
| Provider HPV vaccine recommendations | 1 year | The change in intervention providers' HPV vaccine communication practices compared to control providers' as measured by self-report prior to the intervention and after the intervention. |
| Parents' experiences and preferences regarding provider communication about HPV vaccines | 1 year | The change in intervention parents' experiences and preferences regarding provider HPV vaccine communication compared to parents of adolescents attending control practices as measured by self report prior to the intervention and after the intervention. |
Countries
United States
Outcome results
None listed